Financial Summary (All financials)
In millions, except per share items | Jan-28-23 | Jan-29-22 | Jan-30-21 | Feb-01-20 | Feb-02-19 |
Revenues | 6,036.0 | 5,807.1 | 4,920.2 | 4,434.5 | 4,392.2 |
Revenue growth | 3.9% | 18.0% | 11.0% | 1.0% | |
Cost of goods sold | 3,608.9 | 3,380.5 | 2,813.5 | 2,528.0 | 2,487.3 |
Gross profit | 2,427.1 | 2,426.6 | 2,106.7 | 1,906.5 | 1,904.8 |
Gross margin | 40.2% | 41.8% | 42.8% | 43.0% | 43.4% |
Selling, general and administrative | 2,201.5 | 2,160.5 | 1,912.3 | 1,776.9 | 1,746.4 |
EBIT | 238.5 | 277.0 | 200.9 | 132.0 | -216.8 |
EBIT margin | 4.0% | 4.8% | 4.1% | 3.0% | -4.9% |
Pre-tax income | 112.3 | 202.4 | -41.6 | -142.1 | -459.6 |
Income taxes | 35.3 | 53.5 | -3.3 | -35.7 | -45.8 |
Tax rate | 31.5% | 26.4% | 8.0% | 25.1% | 10.0% |
Net income | 89.9 | 164.4 | -26.5 | -95.9 | -413.8 |
Net margin | 1.5% | 2.8% | -0.5% | -2.2% | -9.4% |
|
Diluted EPS | $0.34 | $0.62 | ($0.13) | ($0.46) | |
Shares outstanding (diluted) | 266.0 | 265.3 | 210.7 | 208.9 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|